Switzerland· 30897048
Alkeran
A melphalan product containing melphalanum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Melphalan is registered in 17 of 19 countries.
Countries holding a registration under ATC L01AA03 (melphalan), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 10 of them publish a price we can compare per daily dose
Melphalan · ATC L01AA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of melphalan costs, country by country.
Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.79 in Italy to $3.83 in Switzerland — a ×4.8 gap.
- Switzerland: $3.83 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Melphalan · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.83
- FR France$0.89
- IT Italy$0.79
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- melphalanum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L01AA03
- ATC class
- Melphalan
- Defined daily dose
- 2 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768030897048425 StkCHF 48.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for melphalan.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Melphalan · interactions on record
242 records
- 32 severe
- 100 moderate
- 25 minor
- 85 info
Most severe, free to view
- Nalidixic acidJ01MB02severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Melphalan in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAlkeranAspen Pharma Trading Limited
- SpainALKERAN 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAspen Pharma Trading Limited
- FranceALKERAN 2 mg, comprimé pelliculéASPEN PHARMA TRADING (IRLANDE)
- IrelandAlkeran 2 mg Film-coated TabletsAspen Pharma Trading Limited
- IcelandAlkeranAspen Pharma Trading Limited
- NetherlandsAlkeran 2 mg, filmomhulde tablettenAspen Pharma Trading Limited
- NorwayAlkeranAspen Pharma Trading Limited
- PolandAlkeranAspen Pharma Trading Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Alkeran, Melphalan Hikma
- Belgium · Alkeran, Melfalan Tillomed
- Cyprus · Melfalan Tillomed
- Czechia · Alkeran, Melphalan Zentiva
- Germany · Alkeran, Melphalan
- Denmark · Alkeran, Melphalan Macure
- Estonia · Alkeran
- Spain · Alkeran, Melfalán Aspen
- Finland · Alkeran, Melphalan Macure
- France · Alkeran, Melphalan Hikma
- United Kingdom (Northern Ireland) · Melphalan, Melphalan Accord-Uk
- Greece · Demephan, Melphalan Tillomed
- Croatia · Melfalan Pliva, Melfalan Tillomed
- Hungary · Melphalan Teva, Melphalan Zentiva
- Ireland · Alkeran, Melphalan Tillomed
- Iceland · Alkeran, Phelinun
- Italy · Alkeran, Melfalan Hikma
- Liechtenstein · Phelinun
- Lithuania · Alkeran, Melphalan Zentiva
- Luxembourg · Alkeran, Melphalan Aqvida
- Latvia · Alkeran, Melphalan Tillomed
- Netherlands · Alkeran, Melfalan Amarox
- Norway · Alkeran, Melphalan Macure
- Poland · Alkeran, Melphalan Zentiva
- Portugal · Alkeran, Melfalano Eugia
- Romania · Alkeran, Melfalan Teva
- Sweden · Alkeran, Melfalan Sun
- Slovenia · Alkeran, Melfalan Teva
- Slovakia · Alkeran, Melphalan Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e499a04a-5a4c-4b6a-a28c-f89ae263d25c GET /v1/drugs/e499a04a-5a4c-4b6a-a28c-f89ae263d25c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "melphalanum 2 mg",
"valid_from": "1965-03-15",
"limitations": "[{\"description\":\"Vergütung ausschliesslich bei Behandlung des multiplen Myeloms.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-01-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 2 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1965-03-15",
"self_retention_pct": 10
}See everything about melphalan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.